Pfizer’s COVID-19 vaccine gets full FDA approval

The Food and Drug Administration granted full approval to the Pfizer / BioNTech COVID-19 vaccine, another landmark in the historic immunization campaign. The vaccine was previously available to people over the age of 12 in the United States under an emergency use authorization. Now, it’s officially licensed in the United States.
With full approval, Pfizer and BioNTech can directly market the shot to consumers. The approval may also push more companies and schools to mandate vaccinations. While it’s legal for them to require vaccinations under an emergency authorization, some have been reluctant to do so.
The companies needed to provide six months of safety and efficacy data on their vaccine to the FDA in order to submit their…
Continue reading…